Piper Jaffray assumes Integra LifeSciences coverage — 5 things to know

Piper Jaffray began coverage of Integra LifeSciences shares in a research note issued yesterday, according to a Sleek Monkey report.

Advertisement

Here are five things to know about Integra LifeSciences:

 

1. Piper Jaffray analysts set an “overweight” rating for the stock.
2. Integra traded up yesterday 0.41 percent.
3. Trading volume was 49,458.
4. Integra’s market cap is $1.94 billion.
5. The stock price hit $59.30 with a 52-week high of $61.26.

 

More articles on orthopedic devices:
Medtronic is headed for strong 2015—8 reasons why
5 spine, orthopedic device launches & releases
Lumin Health names two new executives

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.